Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy
Authors:
- M. ContinMCM. Contin
- S. MohamedSMS. Mohamed
- F. AlbaniFAF. Albani
- R. RivaRRR. Riva
- A. BaruzziABA. Baruzzi
- 1 February 2012
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 98 (2-3) , 130-134
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsyEpilepsy Research, 2011
- Age and Comedications Influence Levetiracetam Pharmacokinetics in ChildrenPediatric Neurology, 2010
- Levetiracetam monotherapy for late poststroke seizures in the elderlyEpilepsy & Behavior, 2008
- Simple and validated HPLC–UV analysis of levetiracetam in deproteinized plasma of patients with epilepsyJournal of Chromatography B, 2008
- Effect of Age and Comedication on Levetiracetam Pharmacokinetics and TolerabilityEpilepsia, 2007
- Levetiracetam Therapeutic Monitoring in Patients with EpilepsyTherapeutic Drug Monitoring, 2004
- Serum Concentrations of Levetiracetam in Epileptic Patients: The Influence of Dose and Co-medicationTherapeutic Drug Monitoring, 2003
- Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trialEpilepsy & Behavior, 2003
- The pharmacokinetic characteristics of levetiracetamMethods and Findings in Experimental and Clinical Pharmacology, 2003
- Incidence and Clinical Characterization of Unprovoked Seizures in Adults: A Prospective Population‐Based StudyEpilepsia, 1996